You are the data analyst for a large double-masked, randomized clinical trial. You have randomized 10,000 subjects: 5,000 to the treatment and 5,000 to a placebo. After randomization, you determine that 712 subjects in the treatment arm are unable to tolerate the full course of treatment (i.e. didn't complete the intervention). Prior to completing the analysis for the study should you remove those 712 subjects from your treatment arm, leaving 4,288 in your analysis